Survey on Itch in Outpatients of a University Clinic

Itch Clinical Trial

Official title:

Survey on Itch in Outpatients of a University Clinic

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03901443
• Other study ID #: UBE 15/114, sp15Mueller3
• Status: Completed
• Start date: December 9, 2015
• Est. completion date: April 30, 2016

Study information

• Verified date: April 2019
• Source: University Hospital, Basel, Switzerland
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study is to investigate the pruriception (i.e. the perception of the character and intensity of itch), the impact of itch on quality of life, the response to itch and the subjective efficacy and preferences of the different treatment options among patients with different skin diseases. Better insights into these aspects might help to optimize itch treatment in clinical Settings.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 300
• Est. completion date: April 30, 2016
• Est. primary completion date: April 30, 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• outpatients suffering from itch

Exclusion Criteria:

• outpatients (suffering from itch) not willing or able to participate

Related Conditions & MeSH terms

• Itch

Intervention

Other:
• Survey on itch
self-administered patient questionnaire regarding the different aspects of itch

Locations

Country	Name	City	State
Switzerland	Department of Dermatology, University Hospital Basel	Basel

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Basel, Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	itch intensity	Questions regarding itch perception (NRS 0-10; 0 = no itch, 10 = worst imaginable itch) experienced at the moment, within the last 7 days, within the last month	single time point assessment at baseline
Primary	itch perception	Questions regarding situations in which the itch is especially bad (multiple choice options regarding day time, daily situations, season); objective assessment in which respondents are asked to select answers from the choices offered as a list	single time point assessment at baseline
Primary	impact of itch on quality of life	Questions regarding strength of impact of itch on quality of life (NRS 0-10; 0 = no impact, 10 = extreme)	single time point assessment at baseline
Primary	quality of sleep	Questions regarding sleep disturbance by itch (Does itch disturb the patient's sleep and/or sleep of other persons? (yes/no))	single time point assessment at baseline
Primary	days missing at work	Approximate number of days missing at work due to itch within last 6 months	single time point assessment at baseline
Primary	helpfulness of common itch therapies	Questions regarding helpfulness of common itch therapies (NRS 0-10; 0 = no reduction in itch, 10; = complete reduction of itch; additionally free text options to indicate specific creams, tablets or alternative medicine)	single time point assessment at baseline
Primary	preferred treatment options	Questions regarding preferred treatment options (NRS 0- 10; 0 = unimportant, 10 = most important; including additional free text option)	single time point assessment at baseline